The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease

Advances in Cancer Research

Volumn 120, Issue , 2013, Pages 159-192

  Noch, Evan K ^a   Khalili, Kamel ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

AEG 1 MTDH LYRIC; Cancer; CNS; Glioblastoma; HIV

Indexed keywords

ADAM PROTEIN; ADAMTS1 PROTEIN; ASTROCYTE ELEVATED GENE 1 PROTEIN; BEVACIZUMAB; BIOLOGICAL MARKER; CISPLATIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; DEOXYGLUCOSE; DNA VACCINE; DOXORUBICIN; GLUTAMIC ACID; I KAPPA B; LONIDAMINE; LYSINE RICH CEACAM 1 ASSOCIATED PROTEIN; MATRIX METALLOPROTEINASE; METADHERIN; MICRORNA; MULTIDRUG RESISTANCE PROTEIN 1; ONCOPROTEIN; PANOBINOSTAT; PEPTIDE VACCINE; PROTEIN KINASE B; RNA INDUCED SILENCING COMPLEX; SELUMETINIB; TEMOZOLOMIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIBODY PRODUCTION; ARTICLE; AUTOPHAGY; CANCER PROGNOSIS; CANCER RESISTANCE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME 8Q; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG TARGETING; ENDOPLASMIC RETICULUM STRESS; EXCITOTOXICITY; GENE INDUCTION; GENETIC POLYMORPHISM; GLIOBLASTOMA; GLIOSIS; GLUCOSE METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUNTINGTON CHOREA; METASTASIS; MIGRAINE; NEUROPATHOLOGY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR INVASION; TUMOR MICROENVIRONMENT; VIRUS REPLICATION;

AEG-1/MTDH/LYRIC; CANCER; CNS; GLIOBLASTOMA; HIV;

ANIMALS; AUTOPHAGY; BRAIN NEOPLASMS; CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; DRUG RESISTANCE, NEOPLASM; GENETIC ASSOCIATION STUDIES; HUMANS; NEOPLASM INVASIVENESS;

EID: 84880927015     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-401676-7.00006-1     Document Type: Chapter

References (122)

1. Alexander B.M., Pinnell N., Wen P.Y., D'Andrea A. Targeting DNA repair and the cell cycle in glioblastoma. Journal of Neuro-Oncology 2012, 107:463-477.
2. Andreeva A.Y., Krause E., Müller E.C., Blasig I.E., Utepbergenov D.I. Protein kinase C regulates the phosphorylation and cellular localization of occludin. The Journal of Biological Chemistry 2001, 276:38480-38486.
3. Anttila V., Stefansson H., Kallela M., Todt U., Terwindt G.M., Calafato M.S., et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nature Genetics 2010, 42:869-873.
4. Ash S.C., Yang D.Q., Britt D.E. LYRIC/AEG-1/MTDH/LYRIC overexpression modulates BCCIPalpha protein levels in prostate tumor cells. Biochemical and Biophysical Research Communications 2008, 371:333-338.
5. Benyahia B., Huguet S., Decleves X., Mokhtari K., Criniere E., Bernaudin J.F., et al. Multidrug resistance-associated protein MRP1 expression in human gliomas: Chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. Journal of Neuro-Oncology 2004, 66:65-70.
6. Bernardo M.V., Yelo E., Gimeno L., Campillo J.A., Parrado A. Identification of apoptosis-related PLZF target genes. Biochemical and Biophysical Research Communications 2007, 359:317-322.
7. Bhutia S.K., Kegelman T.P., Das S.K., Azab B., Su Z.Z., Lee S.G., et al. Astrocyte elevated gene-1 induces protective autophagy. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:22243-22248.
8. Blanco M.A., Aleckovic M., Hua Y., Li T., Wei Y., Xu Z., et al. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. The Journal of Biological Chemistry 2011, 286:19982-19992.
9. Britt D.E., Yang D.F., Yang D.Q., Flanagan D., Callanan H., Lim Y.P., et al. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Experimental Cell Research 2004, 300:134-148.
10. Bronger H., Konig J., Kopplow K., Steiner H.H., Ahmadi R., Herold-Mende C., et al. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Research 2005, 65:11419-11428.
11. Brown D.M., Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004, 5:365-374.
12. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
13. Buchan J.R., Parker R. Eukaryotic stress granules: The ins and outs of translation. Molecular Cell 2009, 36:932-941.
14. Carnemolla A., Fossale E., Agostoni E., Michelazzi S., Calligaris R., De Maso L., et al. Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease. The Journal of Biological Chemistry 2009, 284:18167-18173.
15. Carpenter S., Carlson T., Dellacasagrande J., Garcia A., Gibbons S., Hertzog P., et al. TRIL, a functional component of the TLR4 signaling complex, highly expressed in brain. The Journal of Immunology 2009, 183:3989-3995.
16. Chen X., Dong K., Long M., Lin F., Wang X., Wei J., et al. Serum anti-AEG-1/MTDH/LYRIC auto-antibody is a potential novel biomarker for malignant tumors. Oncology Letters 2012, 4:319-323.
17. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., et al. A quantitative atlas of mitotic phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10762-10767.
18. Dolecek T.A., Propp J.M., Stroup N.E., Kruchko C. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009. Neuro-Oncol 2012, 14(suppl 5):v1-v49.
19. El Mjiyad N., Caro-Maldonado A., Ramirez-Peinado S., Munoz-Pinedo C. Sugar-free approaches to cancer cell killing. Oncogene 2011, 30:253-264.
20. Emdad L., Lee S.G., Su Z.Z., Jeon H.Y., Boukerche H., Sarkar D., et al. Astrocyte elevated gene-1 (AEG-1/MTDH/LYRIC) functions as an oncogene and regulates angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:21300-21305.
21. Emdad L., Sarkar D., Lee S.G., Su Z.Z., Yoo B.K., Dash R., et al. Astrocyte elevated gene-1: A novel target for human glioma therapy. Molecular Cancer Therapeutics 2010, 9:79-88.
22. Emdad L., Sarkar D., Su Z.Z., Randolph A., Boukerche H., Valerie K., et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis. Cancer Research 2006, 66:1509-1516.
23. Engeland C.E., Oberwinkler H., Schümann M., Krause E., Müller G.A., Kräusslich H.G. The cellular protein lyric interacts with HIV-1 Gag. Journal of Virology 2011, 85:13322-13332.
24. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
25. Friedman H.S., Prados M.D., Wen P.Y., Mikkelsen T., Schiff D., Abrey L.E., et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2009, 27:4733-4740.
26. Fujishiro M., Gotoh Y., Katagiri H., Sakoda H., Ogihara T., Anai M., et al. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. The Journal of Biological Chemistry 2001, 276:19800-19806.
27. Fricker M., Hollinshead M., White N., Vaux D. Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. The Journal of Cellular Biology 1997, 136:531-544.
28. Ghafouri M., Amini S., Khalili K., Sawaya B.E. HIV-1 associated dementia: Symptoms and causes. Retrovirology 2006, 3:28.
29. Gravdal K., Halvorsen O.J., Haukaas S.A., Akslen L.A. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clinical Cancer Research 2007, 13:7003-7011.
30. Haas B.R., Sontheimer H. Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion. Cancer Research 2010, 70:5597-5606.
31. Hazan R.B., Phillips G.R., Qiao R.F., Norton L., Aaronson S.A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. The Journal of Cell Biology 2000, 148:779-790.
32. Hoelzinger D.B., Demuth T., Berens M.E. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. Journal of the National Cancer Institute 2007, 99:1583-1593.
33. Hu G., Chong R.A., Yang Q., Wei Y., Blanco M.A., Li F., et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009, 15:9-20.
34. Hutvagner G., Simard M.J. Argonaute proteins: Key players in RNA silencing. Nature Reviews. Molecular Cell Biology 2008, 9:22-32.
35. Isozaki Y., Hoshino I., Nohata N., Kinoshita T., Akutsu Y., Hanari N., et al. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. International Journal of Oncology 2012, 41:985-994.
36. Jeon H.Y., Choi M., Howlett E.L., Vozhilla N., Yoo B.K., Lloyd J.A., et al. Expression patterns of astrocyte elevated gene-1 (AEG-1/MTDH/LYRIC) during development of the mouse embryo. Gene Expression Patterns 2010, 10:361-367.
37. Jian-bo X., Hui W., Yu-long H., Chang-hua Z., Long-juan Z., Shi-rong C., et al. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Medical Oncology 2011, 28:455-462.
38. Johnson D.R., Chang S.M. Recent medical management of glioblastoma. Advances in Experimental Medicine and Biology 2012, 746:26-40.
39. Kang D.C., Su Z.Z., Sarkar D., Emdad L., Volsky D.J., Fisher P.B. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1/MTDH/LYRIC. Gene 2005, 353:8-15.
40. Kaur N., Chettiar S., Rathod S., Rath P., Muzumdar D., Shaikh M.L., et al. Wnt3a mediated activation of Wnt/beta-catenin signaling promotes tumor progression in glioblastoma. Molecular and Cellular Neurosciences 2013, 54C:44-57.
41. Khuda I.I., Koide N., Noman A.S., Dagvadorj J., Tumurkhuu G., Naiki Y., et al. Astrocyte elevated gene-1 (AEG-1/MTDH/LYRIC) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling. Immunology 2009, 128:e700-e706.
42. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007, 26:7647-7655.
43. Kirches E., Oda Y., Von Bossanyi P., Diete S., Schneider T., Warich-Kirches M., et al. Mdr1 mRNA expression differs between grade III astrocytomas and glioblastomas. Clinical Neuropathology 1997, 16:34-36.
44. Kirchhausen T. Clathrin. Annual Review of Biochemistry 2000, 69:699-727.
45. Kochanek D.M., Wells D.G. CPEB1 regulates the expression of MTDH/AEG-1/MTDH/LYRIC and glioblastoma cell migration. Molecular Cancer Research 2013, 11:149-160.
46. Kong X., Moran M.S., Zhao Y., Yang Q. Inhibition of metadherin sensitizes breast cancer cells to AZD6244. Cancer Biology & Therapy 2012, 13:43-49.
47. Lee S.G., Jeon H.Y., Su Z.Z., Richards J.E., Vozhilla N., Sarkar D., et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009, 28:2476-2484.
48. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Fisher P.B. Astrocyte elevated gene-1 (AEG-1/MTDH/LYRIC) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:17390-17395.
49. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Franke T.F., Fisher P.B. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2008, 27:1114-1121.
50. Li C., Li R., Song H., Wang D., Feng T., Yu X., et al. Significance of AEG-1/MTDH/LYRIC expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. Journal of Surgical Oncology 2011, 103:184-192.
51. Li J., Yang L., Song L., Xiong H., Wang L., Yan X., et al. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 2009, 28:3188-3196.
52. Ligthart L., de Vries B., Smith A.V., Ikram M.A., Amin N., Hottenga J.J., et al. Meta-analysis of genome-wide association for migraine in six population-based European cohorts. European Journal of Human Genetics 2011, 19:901-907.
53. Lino M.M., Merlo A. PI3Kinase signaling in glioblastoma. Journal of Neuro-Oncology 2011, 103:417-427.
54. Liu I.J., Chiu C.Y., Chen Y.C., Wu H.C. Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. The Journal of Biological Chemistry 2011, 286:9726-9736.
55. Liu H.Y., Liu C.X., Han B., Zhang X.Y., Sun R.P. AEG-1/MTDH/LYRIC is associated with clinical outcome in neuroblastoma patients. Cancer Biomarkers 2012, 11:115-121.
56. Liu H., Song X., Liu C., Xie L., Wei L., Sun R. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. Journal of Experimental & Clinical Cancer Research 2009, 28:19.
57. Liu L., Wu J., Ying Z., Chen B., Han A., Liang Y., et al. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Research 2010, 70:3750-3759.
58. Louis D.N. Molecular pathology of malignant gliomas. Annual Review of Pathology 2006, 1:97-117.
59. Lu H., Guo X., Meng X., Liu J., Allen C., Wray J., et al. The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair. Molecular and Cellular Biology 2005, 25:1949-1957.
60. Lu C., Shervington A. Chemoresistance in gliomas. Molecular and Cellular Biochemistry 2008, 312:71-80.
61. Maragakis N.J., Rothstein J.D. Mechanisms of disease: Astrocytes in neurodegenerative disease. Nature Clinical Practice. Neurology 2006, 2:679-689.
62. Martinez-Outschoorn U.E., Lin Z., Ko Y.H., Goldberg A.F., Flomenberg N., Wang C., et al. Understanding the metabolic basis of drug resistance: Therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle 2011, 10:2521-2528.
63. Martinez-Outschoorn U.E., Pavlides S., Howell A., Pestell R.G., Tanowitz H.B., Sotgia F., et al. Stromal-epithelial metabolic coupling in cancer: Integrating autophagy and metabolism in the tumor microenvironment. The International Journal of Biochemistry & Cell Biology 2011, 43:1045-1051.
64. Martinez-Outschoorn U.E., Whitaker-Menezes D., Pavlides S., Chiavarina B., Bonuccelli G., Casey T., et al. The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox. Cell Cycle 2010, 9:4297-4306.
65. Mazurek S., Boschek C.B., Hugo F., Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Seminars in Cancer Biology 2005, 15:300-308.
66. McArthur J.C., Steiner J., Sacktor N., Nath A. Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Annals of Neurology 2010, 67:699-714.
67. Meng X., Brachova P., Yang S., Xiong Z., Zhang Y., Thiel K.W., et al. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment. PLoS One 2011, 6:e20920.
68. Meng X., Fan J., Shen Z. Roles of BCCIP in chromosome stability and cytokinesis. Oncogene 2007, 26:6253-6260.
69. Meng X., Zhu D., Yang S., Wang X., Xiong Z., Zhang Y., et al. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein. The Journal of Biological Chemistry 2012, 287:4485-4491.
70. Mentlein R., Hattermann K., Held-Feindt J. Lost in disruption: Role of proteases in glioma invasion and progression. Biochimica et Biophysica Acta 2012, 1825:178-185.
71. Moser J.J., Fritzler M.J. The microRNA and messengerRNA profile of the RNA-induced silencing complex in human primary astrocyte and astrocytoma cells. PLoS One 2010, 5:e13445.
72. Nakai E., Park K., Yawata T., Chihara T., Kumazawa A., Nakabayashi H., et al. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma. Cancer Investigation 2009, 27:901-908.
73. Nakamura N., Ramaswamy S., Vazquez F., Signoretti S., Loda M., Sellers W.R. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Molecular and Cellular Biology 2000, 20:8969-8982.
74. Niethammer A.G., Xiang R., Becker J.C., Wodrich H., Pertl U., Karsten G., et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nature Medicine 2002, 8:1369-1375.
75. Noch E., Bookland M., Khalili K. Astrocyte-elevated gene-1 (AEG-1/MTDH/LYRIC) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biology & Therapy 2011, 11:32-39.
76. Noch E., Khalili K. Molecular mechanisms of necrosis in glioblastoma: The role of glutamate excitotoxicity. Cancer Biology & Therapy 2009, 8:1791-1797.
77. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Sakurai D., Fujimura L., et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH/LYRIC/MTDH in head and neck squamous cell carcinoma (HNSCC). Journal of Human Genetics 2011, 56:595-601.
78. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
79. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Science Signaling 2010, 3:ra3.
80. Pertl U., Wodrich H., Ruehlmann J.M., Gillies S.D., Lode H.N., Reisfeld R.A. Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood 2003, 101:649-654.
81. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998, 282:2085-2088.
82. Purow B., Schiff D. Advances in the genetics of glioblastoma: Are we reaching critical mass?. Nature Reviews. Neurology 2009, 5:419-426.
83. Qian B.J., Yan F., Li N., Liu Q.L., Lin Y.H., Liu C.M., et al. MTDH/AEG-1/MTDH/LYRIC-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer. Cancer Immunology, Immunotherapy 2011, 60:883-893.
84. Ransom C.B., O'Neal J.T., Sontheimer H. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2001, 21:7674-7683.
85. Raza S.M., Lang F.F., Aggarwal B.B., Fuller G.N., Wildrick D.M., Sawaya R. Necrosis and glioblastoma: A friend or a foe? A review and a hypothesis. Neurosurgery 2002, 51:2-12. discussion 12-13.
86. Rice J., Ottensmeier C.H., Stevenson F.K. DNA vaccines: Precision tools for activating effective immunity against cancer. Nature Reviews. Cancer 2008, 8:108-120.
87. Rich J.N., Guo C., McLendon R.E., Bigner D.D., Wang X.F., Counter C.M. A genetically tractable model of human glioma formation. Cancer Research 2001, 61:3556-3560.
88. Roeb W., Boyer A., Cavenee W.K., Arden K.C. PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:18085-18090.
89. Roussel B.D., Kruppa A.J., Miranda E., Crowther D.C., Lomas D.A., Marciniak S.J. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurology 2013, 12:105-118.
90. Rubenstein B.M., Kaufman L.J. The role of extracellular matrix in glioma invasion: A cellular Potts model approach. Biophysical Journal 2008, 95:5661-5680.
91. Sabri F., Titanji K., De Milito A., Chiodi F. Astrocyte activation and apoptosis: Their roles in the neuropathology of HIV infection. Brain Pathology 2003, 13:84-94.
92. Sakakibara A., Furuse M., Saitou M., Ando-Akatsuka Y., Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. The Journal of Cell Biology 1997, 137:1393-1401.
93. Sampson J.H., Heimberger A.B., Archer G.E., Aldape K.D., Friedman A.H., Friedman H.S., et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2010, 28:4722-4729.
94. Sarkar D., Park E.S., Emdad L., Lee S.G., Su Z.Z., Fisher P.B. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Research 2008, 68:1478-1484.
95. Schaich M., Kestel L., Pfirrmann M., Robel K., Illmer T., Kramer M., et al. A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 2009, 20:175-181.
96. Scherer H. Structural development in gliomas. American Journal of Cancer 1938, 34:333-351.
97. Schulz M., Brandner S., Eberhagen C., Eckardt-Schupp F., Larsen M.R., Andrae U. Quantitative phosphoproteomic analysis of early alterations in protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Proteome Research 2013, 12:866-882.
98. Seoane J., Le H.V., Shen L., Anderson S.A., Massagué J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004, 117:211-223.
99. Sotgia F., Martinez-Outschoorn U.E., Pavlides S., Howell A., Pestell R.G., Lisanti M.P. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Research 2011, 13:213.
100. Spiegl-Kreinecker S., Buchroithner J., Elbling L., Steiner E., Wurm G., Bodenteich A., et al. Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes. Journal of Neuro-Oncology 2002, 57:27-36.
101. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England Journal of Medicine 2005, 352:987-996.
102. Su Z.Z., Chen Y., Kang D.C., Chao W., Simm M., Volsky D.J., et al. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene 2003, 306:67-78.
103. Sutherland H.G., Lam Y.W., Briers S., Lamond A.I., Bickmore W.A. 3D3/lyric: A novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Experimental Cell Research 2004, 294:94-105.
104. Thirkettle H.J., Girling J., Warren A.Y., Mills I.G., Sahadevan K., Leung H., et al. LYRIC/AEG-1/MTDH/LYRIC is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clinical Cancer Research 2009, 15:3003-3013.
105. Thirkettle H.J., Mills I.G., Whitaker H.C., Neal D.E. Nuclear LYRIC/AEG-1/MTDH/LYRIC interacts with PLZF and relieves PLZF-mediated repression. Oncogene 2009, 28:3663-3670.
106. Thuringer D., Hammann A., Benikhlef N., Fourmaux E., Bouchot A., Wettstein G., et al. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells. The Journal of Biological Chemistry 2011, 286:3418-3428.
107. Vartak-Sharma N., Ghorpade A. Astrocyte elevated gene-1 regulates astrocyte responses to neural injury: Implications for reactive astrogliosis and neurodegeneration. Journal of Neuroinflammation 2012, 9:195.
108. Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analysis of mouse liver. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:1488-1493.
109. Wang J., Wang Q., Cui Y., Liu Z.Y., Zhao W., Wang C.L., et al. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. Journal of Neuro-Oncology 2012, 106:473-484.
110. Warburg O. On the origin of cancer cells. Science (New York, NY) 1956, 123:309-314.
111. Wick W., Platten M., Weller M. Glioma cell invasion: Regulation of metalloproteinase activity by TGF-beta. Journal of Neuro-Oncology 2001, 53:177-185.
112. Xia Z., Zhang N., Jin H., Yu Z., Xu G., Huang Z. Clinical significance of astrocyte elevated gene-1 expression in human oligodendrogliomas. Clinical Neurology and Neurosurgery 2010, 112:413-419.
113. Yang Y., Wu J., Guan H., Cai J., Fang L., Li J., et al. MiR-136 promotes apoptosis of glioma cells by targeting AEG-1/MTDH/LYRIC and Bcl-2. FEBS Letters 2012, 586:3608-3612.
114. Yoo B.K., Chen D., Su Z.Z., Gredler R., Yoo J., Shah K., et al. Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Research 2010, 70:3249-3258.
115. Yoo B.K., Emdad L., Lee S.G., Su Z.Z., Santhekadur P., Chen D., et al. Astrocyte elevated gene-1 (AEG-1/MTDH/LYRIC): A multifunctional regulator of normal and abnormal physiology. Pharmacology & Therapeutics 2011, 130:1-8.
116. Yoo B.K., Emdad L., Su Z.Z., Villanueva A., Chiang D.Y., Mukhopadhyay N.D., et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. The Journal of Clinical Investigation 2009, 119:465-477.
117. Yoo B.K., Gredler R., Vozhilla N., Su Z.Z., Chen D., Forcier T., et al. Identification of genes conferring resistance to 5-fluorouracil. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:12938-12943.
118. Yoo B.K., Santhekadur P.K., Gredler R., Chen D., Emdad L., Bhutia S., et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 2011, 53:1538-1548.
119. Yuan C., Li X., Yan S., Yang Q., Liu X., Kong B. The MTDH (-470G>A) polymorphism is associated with ovarian cancer susceptibility. PLoS One 2012, 7:e51561.
120. Zhao Y., Kong X., Li X., Yan S., Yuan C., Hu W., et al. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One 2011, 6:e29363.
121. Zhou Z., Deng H., Yan W., Huang H., Deng Y., Li Y., et al. Expression of metadherin/AEG-1/MTDH/LYRIC gene is positively related to orientation chemotaxis and adhesion of human hepatocellular carcinoma cell lines of different metastatic potentials. Journal of Huazhong University of Science and Technology. Medical Sciences 2012, 32:353-357.
122. Zhu K., Dai Z., Pan Q., Wang Z., Yang G.H., Yu L., et al. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clinical Cancer Research 2011, 17:7294-7302.